Analysen zu AstraZeneca PLC
| 29.07.25 | AstraZeneca Buy | UBS AG | |
| 29.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.07.25 | AstraZeneca Outperform | Bernstein Research | |
| 24.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 23.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 22.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 21.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 16.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 14.07.25 | AstraZeneca Buy | UBS AG | |
| 14.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.07.25 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.07.25 | AstraZeneca Buy | UBS AG | |
| 03.07.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 02.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 01.07.25 | AstraZeneca Buy | UBS AG | |
| 26.06.25 | AstraZeneca Outperform | Bernstein Research | |
| 24.06.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.06.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.06.25 | AstraZeneca Buy | UBS AG | |
| 02.06.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 02.06.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 16.05.25 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.05.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 01.05.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 29.04.25 | AstraZeneca Outperform | Bernstein Research | |
| 29.04.25 | AstraZeneca Buy | UBS AG | |
| 28.04.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 22.04.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 10.04.25 | AstraZeneca Buy | UBS AG | |
| 09.04.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 09.04.25 | AstraZeneca Outperform | Bernstein Research | |
| 03.04.25 | AstraZeneca Outperform | Bernstein Research | |
| 01.04.25 | AstraZeneca Buy | UBS AG | |
| 01.04.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.03.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 26.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 17.03.25 | AstraZeneca Outperform | Bernstein Research | |
| 17.03.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 17.03.25 | AstraZeneca Buy | UBS AG | |
| 17.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 12.03.25 | AstraZeneca Buy | UBS AG | |
| 10.03.25 | AstraZeneca Buy | UBS AG | |
| 10.03.25 | AstraZeneca Buy | UBS AG | |
| 04.03.25 | AstraZeneca Outperform | Bernstein Research | |
| 26.02.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 26.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 26.02.25 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.02.25 | AstraZeneca Outperform | Bernstein Research | |
| 19.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. |
Aktuelle Aktienanalysen
| 19.03.26 | thyssenkrupp nucera Buy | Deutsche Bank AG | |
| 19.03.26 | Shell Overweight | Barclays Capital | |
| 19.03.26 | Sartorius vz. Buy | Deutsche Bank AG | |
| 19.03.26 | IONOS Overweight | JP Morgan Chase & Co. | |
| 19.03.26 | Fraport Overweight | Barclays Capital | |
| 19.03.26 | Zalando Overweight | Barclays Capital | |
| 19.03.26 | freenet Equal Weight | Barclays Capital | |
| 19.03.26 | easyJet Sell | Deutsche Bank AG | |
| 19.03.26 | DocMorris Equal Weight | Barclays Capital | |
| 19.03.26 | LANXESS Underweight | Barclays Capital | |
| 19.03.26 | Ryanair Buy | Deutsche Bank AG | |
| 19.03.26 | AUMOVIO Market-Perform | Bernstein Research | |
| 19.03.26 | Lufthansa Hold | Deutsche Bank AG | |
| 19.03.26 | AIR France-KLM Hold | Deutsche Bank AG | |
| 19.03.26 | RATIONAL Underperform | RBC Capital Markets | |
| 19.03.26 | Nemetschek Buy | Jefferies & Company Inc. | |
| 19.03.26 | PVA TePla Buy | Jefferies & Company Inc. | |
| 19.03.26 | Nemetschek Overweight | JP Morgan Chase & Co. | |
| 19.03.26 | LANXESS Underweight | JP Morgan Chase & Co. | |
| 19.03.26 | Vonovia Overweight | JP Morgan Chase & Co. | |
| 19.03.26 | Saint-Gobain Overweight | JP Morgan Chase & Co. | |
| 19.03.26 | Heidelberg Materials Overweight | JP Morgan Chase & Co. | |
| 19.03.26 | LANXESS Hold | Jefferies & Company Inc. | |
| 19.03.26 | DocMorris Buy | Jefferies & Company Inc. | |
| 19.03.26 | Scout24 Overweight | JP Morgan Chase & Co. | |
| 19.03.26 | freenet Sell | Goldman Sachs Group Inc. | |
| 19.03.26 | Ryanair Outperform | RBC Capital Markets | |
| 19.03.26 | International Consolidated Airlines Outperform | RBC Capital Markets | |
| 19.03.26 | easyJet Outperform | RBC Capital Markets | |
| 19.03.26 | Shell Buy | Goldman Sachs Group Inc. | |
| 19.03.26 | Lufthansa Sector Perform | RBC Capital Markets | |
| 19.03.26 | AIR France-KLM Sector Perform | RBC Capital Markets | |
| 19.03.26 | TotalEnergies Neutral | Goldman Sachs Group Inc. | |
| 19.03.26 | Repsol Neutral | Goldman Sachs Group Inc. | |
| 19.03.26 | BP Buy | Goldman Sachs Group Inc. | |
| 19.03.26 | HelloFresh Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.03.26 | GEA Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.03.26 | adidas Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.03.26 | Vodafone Group Underweight | JP Morgan Chase & Co. | |
| 19.03.26 | ABB Sector Perform | RBC Capital Markets | |
| 19.03.26 | Deutsche Telekom Overweight | JP Morgan Chase & Co. | |
| 19.03.26 | SMA Solar Buy | Jefferies & Company Inc. | |
| 19.03.26 | Akzo Nobel Equal Weight | Barclays Capital | |
| 19.03.26 | Vestas Wind Systems A-S Buy | Jefferies & Company Inc. | |
| 19.03.26 | Nordex Buy | Jefferies & Company Inc. | |
| 19.03.26 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 19.03.26 | Fraport Buy | Jefferies & Company Inc. | |
| 19.03.26 | Beiersdorf Neutral | JP Morgan Chase & Co. | |
| 19.03.26 | Evonik Overweight | Barclays Capital | |
| 19.03.26 | Hannover Rück Sector Perform | RBC Capital Markets |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.